COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 2136: Articles 21351-21360  | Next

Neutralizing antibodies from early cases of SARS-CoV-2 infection offer cross-protection against the SARS-CoV-2 D614G variant.
Lee, C. Y.-P., Amrun, S. N., Chee, R. S.-L., Goh, Y. S., Mak, T. M., Octavia, S., Yeo, N., Chang, Z. W., Tay, M. Z., Torres, A., Carissimo, G., Poh, C. M., Fong, S.-W., Wang, B., Lee, S., Young, B., Tan, S. Y., Leo, Y. S., Lye, D. C. B., Lin, R. T., Maurer-Stroh, S., Lee, B. T. K., Wang, C.-I., Renia, L., Ng, L. F. P.
10.1101/2020.10.08.332544 — Posted: 2020-10-09
idCOV: a pipeline for quick clade identification of SARS-CoV-2 isolates
Zhu, X., Chang, T.-C., Webby, R., Wu, G.
10.1101/2020.10.08.330456 — Posted: 2020-10-09
Batch-Corrected Distance Mitigates Temporal and Spatial Variability for Clustering and Visualization of Single-Cell Gene Expression Data
Liang, S., Dou, J., Iqbal, R., Chen, K.
10.1101/2020.10.08.332080 — Posted: 2020-10-09
Variant analysis of SARS-CoV-2 genomes in the Middle East
Bindayna, K. M., Crinion, S.
10.1101/2020.10.09.332692 — Posted: 2020-10-09
Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2
Gasser, R., Cloutier, M., Prevost, J., Fink, C., Ducas, E., Ding, S., Dussault, N., Landry, P., Tremblay, T., Laforce-Lavoie, A., Lewin, A., Beaudoin-Bussieres, G., Laumaea, A., Medjahed, H., Larochelle, C., Richard, J., Dekaban, G. A., Dikeakos, J. D., Bazin, R., Finzi, A.
10.1101/2020.10.09.333278 — Posted: 2020-10-09
A high-throughput microfluidic nano-immunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultra-low volume dried blood samples
Swank, Z., Michielin, G., Yip, H. M., Cohen, P., Andrey, D. O., Vuilleumier, N., Kaiser, L., Eckerle, I., Meyer, B. J., Maerkl, S. J.
10.1101/2020.10.07.20208280 — Posted: 2020-10-09
COVID-19, Type-2 Diabetes, and Associated Health Outcomes in China: Results from a Nationwide Survey of 10,545 Adults
Shi, Z., Yan, A., Zimmet, P., Sun, X., do Vale Moreira, N. C., Cheskin, L. J., Wang, L., Qu, W., Yan, H., Hussain, A., Wang, Y.
10.1101/2020.10.07.20207282 — Posted: 2020-10-09
EFFECT OF CONVALESCENT PLASMA ON MORTALITY IN PATIENTS WITH COVID-19 PNEUMONIA
Salazar, M. R., Gonzalez, S. E., Regairaz, L., Ferrando, N. S., Gonzalez, V., Carrera, P. M., Munoz, L., Pesci, S. A., Vidal, J. M., Kreplak, N., Estenssoro, E.
10.1101/2020.10.08.20202606 — Posted: 2020-10-09
Role of high-dose exposure in transmission hot zones as a driver of SARS-CoV2 dynamics
Wodarz, D., Komarova, N. L., Schang, L. M.
10.1101/2020.10.07.20208231 — Posted: 2020-10-09
Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis
Asiimwe, I. G., Pushpakom, S., Turner, R., Kolamunnage-Dona, R., Jorgensen, A., Pirmohamed, M.
10.1101/2020.10.07.20208918 — Posted: 2020-10-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).